SI1509215T1 - Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah - Google Patents

Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah

Info

Publication number
SI1509215T1
SI1509215T1 SI200330601T SI200330601T SI1509215T1 SI 1509215 T1 SI1509215 T1 SI 1509215T1 SI 200330601 T SI200330601 T SI 200330601T SI 200330601 T SI200330601 T SI 200330601T SI 1509215 T1 SI1509215 T1 SI 1509215T1
Authority
SI
Slovenia
Prior art keywords
women
prevention
treatment
symptoms
atrophy
Prior art date
Application number
SI200330601T
Other languages
English (en)
Inventor
Taru Blom
Paula Groenroos
Kaija Halonen
Pirkko Haerkoenen
Original Assignee
Hormos Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd
Publication of SI1509215T1 publication Critical patent/SI1509215T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
SI200330601T 2002-06-06 2003-05-14 Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah SI1509215T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38590402P 2002-06-06 2002-06-06
PCT/FI2003/000369 WO2003103649A1 (en) 2002-06-06 2003-05-14 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

Publications (1)

Publication Number Publication Date
SI1509215T1 true SI1509215T1 (sl) 2007-02-28

Family

ID=29736123

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330601T SI1509215T1 (sl) 2002-06-06 2003-05-14 Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah

Country Status (24)

Country Link
EP (1) EP1509215B1 (sl)
JP (1) JP4362442B2 (sl)
KR (1) KR100991157B1 (sl)
CN (2) CN101406464A (sl)
AT (1) ATE344025T1 (sl)
AU (1) AU2003227790B2 (sl)
BR (1) BR0311613A (sl)
CA (1) CA2484542C (sl)
CY (1) CY1105787T1 (sl)
DE (1) DE60309465T2 (sl)
DK (1) DK1509215T3 (sl)
ES (1) ES2270025T3 (sl)
HR (1) HRP20041150B1 (sl)
IL (1) IL164528A (sl)
MX (1) MXPA04012220A (sl)
NO (3) NO334090B1 (sl)
NZ (1) NZ536118A (sl)
PL (1) PL214242B1 (sl)
PT (1) PT1509215E (sl)
RU (1) RU2317816C2 (sl)
SI (1) SI1509215T1 (sl)
UA (1) UA79797C2 (sl)
WO (1) WO2003103649A1 (sl)
ZA (1) ZA200408321B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
ES2392344T3 (es) 2004-05-04 2012-12-07 Hormos Medical Ltd. Formulaciones orales líquidas de ospemifeno
JP5193196B2 (ja) 2006-06-02 2013-05-08 ペア ツリー ウーマンズ ヘルス ケア 萎縮性膣炎の治療の方法
EP2121553B1 (en) 2007-02-14 2012-06-27 Hormos Medical Ltd. Method for the preparation of therapeutically valuable triphenylbutene derivatives
US7504530B2 (en) 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
JP6174156B2 (ja) 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
KR102052133B1 (ko) 2017-08-10 2019-12-05 고려대학교 산학협력단 당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352699A (en) * 1992-04-30 1994-10-04 University Of Massachusetts Medical Center Use of retinioc acid to treat vaginal atrophy
US5461064A (en) * 1993-12-21 1995-10-24 Eli Lilly And Company Methods of inhibiting atrophy of the skin and vagina
US5747059A (en) * 1996-01-11 1998-05-05 Novo Nordisk A/S Atrophy of skin/mucous membrane
KR20020073566A (ko) * 2000-01-28 2002-09-27 앙도르쉐르슈 인코포레이티드 에스트로겐과 배합된 선택적인 에스트로겐 수용체 조절자
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

Also Published As

Publication number Publication date
HRP20041150B1 (en) 2007-06-30
JP2005532353A (ja) 2005-10-27
IL164528A (en) 2010-06-30
IL164528A0 (en) 2005-12-18
RU2317816C2 (ru) 2008-02-27
EP1509215A1 (en) 2005-03-02
CY1105787T1 (el) 2011-02-02
ES2270025T3 (es) 2007-04-01
BR0311613A (pt) 2005-03-08
NO20150487L (no) 2004-12-22
NO339194B1 (no) 2016-11-14
AU2003227790A1 (en) 2003-12-22
AU2003227790B2 (en) 2007-11-29
NO336612B1 (no) 2015-10-12
PL372758A1 (en) 2005-08-08
KR100991157B1 (ko) 2010-11-02
CN101406464A (zh) 2009-04-15
CA2484542C (en) 2010-11-02
RU2004138571A (ru) 2005-06-10
NO20044568L (no) 2004-12-22
ATE344025T1 (de) 2006-11-15
MXPA04012220A (es) 2005-04-08
PL214242B1 (pl) 2013-07-31
DE60309465T2 (de) 2007-08-30
WO2003103649A1 (en) 2003-12-18
CN1658851A (zh) 2005-08-24
JP4362442B2 (ja) 2009-11-11
DK1509215T3 (da) 2007-03-12
HRP20041150A2 (en) 2006-03-31
CN100448437C (zh) 2009-01-07
EP1509215B1 (en) 2006-11-02
UA79797C2 (en) 2007-07-25
NO20131189L (no) 2004-12-22
DE60309465D1 (de) 2006-12-14
CA2484542A1 (en) 2003-12-18
KR20050004292A (ko) 2005-01-12
NZ536118A (en) 2007-08-31
NO334090B1 (no) 2013-12-09
ZA200408321B (en) 2006-07-26
PT1509215E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
AU5844901A (en) Method for the treatment of climacteric disorders in women during or after the menopause
DE60329001D1 (en) 8-hydroxychinolinderivate
TWI371276B (en) Use of brimonidine for manufacture of a medicament for preventing or reducing severity of sensory hypersensitivity associated with migratine
WO2006099261A3 (en) Potent and specific immunoproteasome inhibitors
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
TW200420549A (en) Thiazole derivatives
IL193628A0 (en) Methods and compositions for bactericide, bacteriostatic and anti-inflammation
SI1509215T1 (sl) Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah
WO2003092608A3 (en) Methionine aminopeptidase-2 inhibitors and methods of use thereof
EP1419129A4 (en) USE OF BRANCHED CHAIN FATTY ACIDS AND DERIVATIVES THEREOF FOR THE TREATMENT OF PAIN
DE60004996D1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
AU2002211217A1 (en) Method of treating stroke
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
ES2173044A1 (es) Glicina, n-(n-l- -glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.
SI1817029T1 (sl) Derivati izoksazola za lajĺ anje nevropatskih boleäśin